TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Xxlofoten AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
27,925
|
23,982
|
15,632 |
Financial expenses |
426
|
317
|
403 |
Earnings before taxes |
5,092
|
4,615
|
4,369 |
Total assets |
21,186
|
25,979
|
22,053 |
Current assets |
10,894
|
12,875
|
10,188 |
Current liabilities |
7,678
|
1,751
|
1,849 |
Equity capital |
6,504
|
16,610
|
12,371 |
- share capital |
3,709
![]() |
3,709
![]() |
3,709 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
30.7%
|
63.9%
|
56.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.2%
|
19.2%
|
27.9% |
Return on assets (ROA) |
26.0%
|
19.0%
|
21.6% |
Current ratio |
141.9%
|
735.3%
|
551.0% |
Return on equity (ROE) |
78.3%
|
27.8%
|
35.3% |
Change turnover |
3,943
|
8,350
|
6,313 |
Change turnover % |
16%
|
53%
|
68% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.